These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 26768307)

  • 1. Enhanced delivery of etoposide across the blood-brain barrier to restrain brain tumor growth using melanotransferrin antibody- and tamoxifen-conjugated solid lipid nanoparticles.
    Kuo YC; Wang IH
    J Drug Target; 2016 Aug; 24(7):645-54. PubMed ID: 26768307
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Conjugation of melanotransferrin antibody on solid lipid nanoparticles for mediating brain cancer malignancy.
    Kuo YC; Chao IW
    Biotechnol Prog; 2016 Mar; 32(2):480-90. PubMed ID: 26701338
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Brain targeted delivery of carmustine using solid lipid nanoparticles modified with tamoxifen and lactoferrin for antitumor proliferation.
    Kuo YC; Cheng SJ
    Int J Pharm; 2016 Feb; 499(1-2):10-19. PubMed ID: 26721730
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dual targeting of solid lipid nanoparticles grafted with 83-14 MAb and anti-EGF receptor for malignant brain tumor therapy.
    Kuo YC; Lee CH
    Life Sci; 2016 Feb; 146():222-31. PubMed ID: 26784850
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibition against growth of glioblastoma multiforme in vitro using etoposide-loaded solid lipid nanoparticles with p-aminophenyl-α-D-manno-pyranoside and folic acid.
    Kuo YC; Lee CH
    J Pharm Sci; 2015 May; 104(5):1804-14. PubMed ID: 25694089
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Delivering etoposide to the brain using catanionic solid lipid nanoparticles with surface 5-HT-moduline.
    Kuo YC; Hong TY
    Int J Pharm; 2014 Apr; 465(1-2):132-42. PubMed ID: 24524828
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Targeting delivery of etoposide to inhibit the growth of human glioblastoma multiforme using lactoferrin- and folic acid-grafted poly(lactide-co-glycolide) nanoparticles.
    Kuo YC; Chen YC
    Int J Pharm; 2015 Feb; 479(1):138-49. PubMed ID: 25560309
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Solid lipid nanoparticles carrying chemotherapeutic drug across the blood-brain barrier through insulin receptor-mediated pathway.
    Kuo YC; Shih-Huang CY
    J Drug Target; 2013 Sep; 21(8):730-8. PubMed ID: 23815407
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Targeting delivery of saquinavir to the brain using 83-14 monoclonal antibody-grafted solid lipid nanoparticles.
    Kuo YC; Ko HF
    Biomaterials; 2013 Jul; 34(20):4818-30. PubMed ID: 23545288
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Paclitaxel and naringenin-loaded solid lipid nanoparticles surface modified with cyclic peptides with improved tumor targeting ability in glioblastoma multiforme.
    Wang L; Wang X; Shen L; Alrobaian M; Panda SK; Almasmoum HA; Ghaith MM; Almaimani RA; Ibrahim IAA; Singh T; Baothman AA; Choudhry H; Beg S
    Biomed Pharmacother; 2021 Jun; 138():111461. PubMed ID: 33706131
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Solid lipid nanoparticles surface modified with anti-Contactin-2 or anti-Neurofascin for brain-targeted delivery of medicines.
    Gandomi N; Varshochian R; Atyabi F; Ghahremani MH; Sharifzadeh M; Amini M; Dinarvand R
    Pharm Dev Technol; 2017 May; 22(3):426-435. PubMed ID: 27575893
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Positive-charged solid lipid nanoparticles as paclitaxel drug delivery system in glioblastoma treatment.
    Chirio D; Gallarate M; Peira E; Battaglia L; Muntoni E; Riganti C; Biasibetti E; Capucchio MT; Valazza A; Panciani P; Lanotte M; Annovazzi L; Caldera V; Mellai M; Filice G; Corona S; Schiffer D
    Eur J Pharm Biopharm; 2014 Nov; 88(3):746-58. PubMed ID: 25445304
    [TBL] [Abstract][Full Text] [Related]  

  • 13. PEGylated solid lipid nanoparticles for brain delivery of lipophilic kiteplatin Pt(IV) prodrugs: An in vitro study.
    Arduino I; Depalo N; Re F; Dal Magro R; Panniello A; Margiotta N; Fanizza E; Lopalco A; Laquintana V; Cutrignelli A; Lopedota AA; Franco M; Denora N
    Int J Pharm; 2020 Jun; 583():119351. PubMed ID: 32339634
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Solid lipid nanoparticles for potential doxorubicin delivery in glioblastoma treatment: preliminary in vitro studies.
    Battaglia L; Gallarate M; Peira E; Chirio D; Muntoni E; Biasibetti E; Capucchio MT; Valazza A; Panciani PP; Lanotte M; Schiffer D; Annovazzi L; Caldera V; Mellai M; Riganti C
    J Pharm Sci; 2014 Jul; 103(7):2157-2165. PubMed ID: 24824141
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of intracarotid infusion of etoposide: modification of the permeability of the blood-brain barrier and the blood-tumor barrier in rat brain tumor model.
    Maeda Y; Matsumoto K; Mizumatsu S; Tamiya T; Furuta T; Ohmoto T
    Acta Med Okayama; 1999 Feb; 53(1):5-11. PubMed ID: 10096732
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cationic solid lipid nanoparticles with cholesterol-mediated surface layer for transporting saquinavir to the brain.
    Kuo YC; Wang CC
    Biotechnol Prog; 2014; 30(1):198-206. PubMed ID: 24167123
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Transport of stavudine, delavirdine, and saquinavir across the blood-brain barrier by polybutylcyanoacrylate, methylmethacrylate-sulfopropylmethacrylate, and solid lipid nanoparticles.
    Kuo YC; Su FL
    Int J Pharm; 2007 Aug; 340(1-2):143-52. PubMed ID: 17418986
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Anti-glioma activity and the mechanism of cellular uptake of asiatic acid-loaded solid lipid nanoparticles.
    Garanti T; Stasik A; Burrow AJ; Alhnan MA; Wan KW
    Int J Pharm; 2016 Mar; 500(1-2):305-15. PubMed ID: 26775062
    [TBL] [Abstract][Full Text] [Related]  

  • 19. 'Dendrimer-Cationized-Albumin' encrusted polymeric nanoparticle improves BBB penetration and anticancer activity of doxorubicin.
    Muniswamy VJ; Raval N; Gondaliya P; Tambe V; Kalia K; Tekade RK
    Int J Pharm; 2019 Jan; 555():77-99. PubMed ID: 30448308
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Charge-switchable cell-penetrating peptides for rerouting nanoparticles to glioblastoma treatment.
    Mendes M; Nunes S; Cova T; Branco F; Dyrks M; Koksch B; Vale N; Sousa J; Pais A; Vitorino C
    Colloids Surf B Biointerfaces; 2024 Sep; 241():113983. PubMed ID: 38850741
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.